|
1
|
Gupta G, Singh R, Kotasthane DS and
Kotasthane VD: Myelodysplastic syndromes/neoplasms: Recent
classification system based on World Health Organization
Classification of Tumors - International Agency for Research on
Cancer for Hematopoietic and Lymphoid Tissues. J Blood Med.
1:171–182. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Jemal A, Siegel R, Xu J and Ward E: Cancer
statistics, 2010. CA Cancer J Clin. 60:277–300. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Ghotra VP, Puigvert JC and Danen EH: The
cancer stem cell microenvironment and anti-cancer therapy. Int J
Radiat Biol. 85:955–962. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Kreso A and Dick JE: Evolution of the
cancer stem cell model. Cell Stem Cell. 14:275–291. 2014.
View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Florian S, Sonneck K, Hauswirth AW, Krauth
MT, Schernthaner GH, Sperr WR and Valent P: Detection of molecular
targets on the surface of CD34+/CD38− stem
cells in various myeloid malignancies. Leuk Lymphoma. 47:207–222.
2006. View Article : Google Scholar
|
|
6
|
Al-Hajj M, Wicha MS, Benito-Hernandez A,
Morrison SJ and Clarke MF: Prospective identification of
tumorigenic breast cancer cells. Proc Natl Acad Sci USA.
100:3983–3988. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Sarvi S, Mackinnon AC, Avlonitis N,
Bradley M, Rintoul RC, Rassl DM, Wang W, Forbes SJ, Gregory CD and
Sethi T: CD133+ cancer stem-like cells in small cell
lung cancer are highly tumorigenic and chemoresistant but sensitive
to a novel neuropeptide antagonist. Cancer Res. 74:1554–1565. 2014.
View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Pak MG, Shin DH, Lee CH and Lee MK:
Significance of EpCAM and TROP2 expression in non-small cell lung
cancer. World J Surg Oncol. 10:532012. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Zakaria N, Yusoff NM, Zakaria Z, Lim MN,
Baharuddin PJ, Fakiruddin KS and Yahaya B: Human non-small cell
lung cancer expresses putative cancer stem cell markers and
exhibits the transcriptomic profile of multipotent cells. BMC
Cancer. 15:842015. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Leung EL, Fiscus RR, Tung JW, Tin VP,
Cheng LC, Sihoe AD, Fink LM, Ma Y and Wong MP: Non-small cell lung
cancer cells expressing CD44 are enriched for stem cell-like
properties. PLoS One. 5:e140622010. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Jiang F, Qiu Q, Khanna A, Todd NW, Deepak
J, Xing L, Wang H, Liu Z, Su Y, Stass SA, et al: Aldehyde
dehydrogenase 1 is a tumor stem cell-associated marker in lung
cancer. Mol Cancer Res. 7:330–338. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Chen YC, Hsu HS, Chen YW, Tsai TH, How CK,
Wang CY, Hung SC, Chang YL, Tsai ML, Lee YY, et al: Oct-4
expression maintained cancer stem-like properties in lung
cancer-derived CD133-positive cells. PLoS One. 3:e26372008.
View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Lin S, Sun JG, Wu JB, Long HX, Zhu CH,
Xiang T, Ma H, Zhao ZQ, Yao Q, Zhang AM, et al: Aberrant microRNAs
expression in CD133+/CD326+ human lung
adenocarcinoma initiating cells from A549. Mol Cell. 33:277–283.
2012. View Article : Google Scholar
|
|
14
|
Brabletz T: EMT and MET in metastasis:
Where are the cancer stem cells? Cancer Cell. 22:699–701. 2012.
View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Thiery JP and Lim CT: Tumor dissemination:
An EMT affair. Cancer Cell. 23:272–273. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Tu Z, Xie S, Xiong M, Liu Y, Yang X, Tembo
KM, Huang J, Hu W, Huang X, Pan S, et al: CXCR4 is involved in
CD133-induced EMT in non-small cell lung cancer. Int J Oncol.
50:505–514. 2017.
|
|
17
|
Abba ML, Patil N, Leupold JH and Allgayer
H: MicroRNA regulation of epithelial to mesenchymal transition. J
Clin Med. 5:52016. View Article : Google Scholar
|
|
18
|
Gibbons DL, Lin W, Creighton C, Zhang S,
Lozano G and Kurie J: Use of a murine model of NSCLC to evaluate
the role of the microRNA-200 family in regulating EMT and
metastasis. J Clin Oncol. 27:110062009.
|
|
19
|
Park SM, Gaur AB, Lengyel E and Peter ME:
The miR-200 family determines the epithelial phenotype of cancer
cells by targeting the E-cadherin repressors ZEB1 and ZEB2. Genes
Dev. 22:894–907. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Nishijima N, Seike M, Soeno C, Chiba M,
Miyanaga A, Noro R, Sugano T, Matsumoto M, Kubota K and Gemma A:
miR-200/ZEB axis regulates sensitivity to nintedanib in non-small
cell lung cancer cells. Int J Oncol. 48:937–944. 2016.PubMed/NCBI
|
|
21
|
Cao M, Seike M, Soeno C, Mizutani H,
Kitamura K, Minegishi Y, Noro R, Yoshimura A, Cai L and Gemma A:
miR-23a regulates TGF-β-induced epithelial-mesenchymal transition
by targeting E-cadherin in lung cancer cells. Int J Oncol.
41:869–875. 2012.PubMed/NCBI
|
|
22
|
Hahn S, Jackstadt R, Siemens H, Hünten S
and Hermeking H: SNAIL and miR-34a feed-forward regulation of
ZNF281/ZBP99 promotes epithelial-mesenchymal transition. EMBO J.
32:3079–3095. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Díaz-López A, Moreno-Bueno G and Cano A:
Role of microRNA in epithelial to mesenchymal transition and
metastasis and clinical perspectives. Cancer Manag Res. 6:205–216.
2014.PubMed/NCBI
|
|
24
|
Derynck R, Muthusamy BP and Saeteurn KY:
Signaling pathway cooperation in TGF-β-induced
epithelial-mesenchymal transition. Curr Opin Cell Biol. 31:56–66.
2014. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Ma M, He M, Jiang Q, Yan Y, Guan S, Zhang
J, Yu Z, Chen Q, Sun M, Yao W, et al: miR-487a promotes
TGF-β1-induced EMT, the migration and invasion of breast cancer
cells by directly targeting MAGI2. Int J Biol Sci. 12:397–408.
2016. View Article : Google Scholar :
|
|
26
|
Yu M, Bardia A, Wittner BS, Stott SL, Smas
ME, Ting DT, Isakoff SJ, Ciciliano JC, Wells MN, Shah AM, et al:
Circulating breast tumor cells exhibit dynamic changes in
epithelial and mesenchymal composition. Science. 339:580–584. 2013.
View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Kallergi G, Papadaki MA, Politaki E,
Mavroudis D, Georgoulias V and Agelaki S: Epithelial to mesenchymal
transition markers expressed in circulating tumour cells of early
and metastatic breast cancer patients. Breast Cancer Res.
13:R592011. View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Brabletz T, Jung A, Spaderna S, Hlubek F
and Kirchner T: Opinion: Migrating cancer stem cells - an
integrated concept of malignant tumour progression. Nat Rev Cancer.
5:744–749. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Biddle A, Liang X, Gammon L, Fazil B,
Harper LJ, Emich H, Costea DE and Mackenzie IC: Cancer stem cells
in squamous cell carcinoma switch between two distinct phenotypes
that are preferentially migratory or proliferative. Cancer Res.
71:5317–5326. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Gene Ontology C; Gene Ontology Consortium:
The Gene Ontology (GO) project in 2006. Nucleic Acids Res.
34:D322–D326. 2006. View Article : Google Scholar :
|
|
31
|
Draghici S, Khatri P, Tarca AL, Amin K,
Done A, Voichita C, Georgescu C and Romero R: A systems biology
approach for pathway level analysis. Genome Res. 17:1537–1545.
2007. View Article : Google Scholar : PubMed/NCBI
|
|
32
|
Guo CJ, Pan Q, Li DG, Sun H and Liu BW:
miR-15b and miR-16 are implicated in activation of the rat hepatic
stellate cell: An essential role for apoptosis. J Hepatol.
50:766–778. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
33
|
Joung JG, Hwang KB, Nam JW, Kim SJ and
Zhang BT: Discovery of microRNA-mRNA modules via population-based
probabilistic learning. Bioinformatics. 23:1141–1147. 2007.
View Article : Google Scholar : PubMed/NCBI
|
|
34
|
Zhi F, Shao N, Wang R, Deng D, Xue L, Wang
Q, Zhang Y, Shi Y, Xia X, Wang S, et al: Identification of 9 serum
microRNAs as potential noninvasive biomarkers of human astrocytoma.
Neuro Oncol. 17:383–391. 2015. View Article : Google Scholar :
|
|
35
|
Zheng Y, Lv X, Wang X, Wang B, Shao X,
Huang Y, Shi L, Chen Z, Huang J and Huang P: miR-181b promotes
chemoresistance in breast cancer by regulating Bim expression.
Oncol Rep. 35:683–690. 2016.
|
|
36
|
Wang J, Sai K, Chen FR and Chen ZP:
miR-181b modulates glioma cell sensitivity to temozolomide by
targeting MEK1. Cancer Chemother Pharmacol. 72:147–158. 2013.
View Article : Google Scholar : PubMed/NCBI
|
|
37
|
Liu Y, Hu X, Xia D and Zhang S:
MicroRNA-181b is down-regulated in non-small cell lung cancer and
inhibits cell motility by directly targeting HMGB1. Oncol Lett.
12:4181–4186. 2016.PubMed/NCBI
|
|
38
|
Cinegaglia NC, Andrade SC, Tokar T,
Pinheiro M, Severino FE, Oliveira RA, Hasimoto EN, Cataneo DC,
Cataneo AJ, Defaveri J, et al: Integrative transcriptome analysis
identifies deregulated microRNA-transcription factor networks in
lung adenocarcinoma. Oncotarget. 7:28920–28934. 2016.PubMed/NCBI
|
|
39
|
Tian F, Shen Y, Chen Z, Li R, Lu J and Ge
Q: Aberrant miR-181b-5p and miR-486-5p expression in serum and
tissue of non-small cell lung cancer. Gene. 591:338–343. 2016.
View Article : Google Scholar : PubMed/NCBI
|
